NextCure, Inc.

New Filing
CIK: 0001661059·Biotechnology·DELAWARE·Filed: Dec 9, 2025
Total Offering

$21,500,000

Amount Sold

$21,500,000

Investors

12

First Sale

Nov 12, 2025

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)

Related Persons

NameRole
Michael Richman
Executive Officer, Director
Steven P. Cobourn
Executive Officer
David Kabakoff
Director
Elaine V. Jones
Director
John G. Houston
Director
Stephen Webster
Director
Ellen G. Feigal
Director
Anne Borgman
Director
Udayan Guha
Executive Officer
Timothy Mayer
Executive Officer
Sourav Kundu
Executive Officer
Kevin Shaw
Executive Officer

Company

NextCure, Inc.

9000 VIRGINIA MANOR ROAD

BELTSVILLE, MD, 20705

240-399-4900

SEC Filing

0001104659-25-119801

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free